Currently out of the existing stock ratings of Justin Kim, 49 are a BUY (87.5%), 7 are a HOLD (12.5%).

Justin Kim

Work Performance Price Targets & Ratings Chart

Analyst Justin Kim, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 57.89% that have a potential upside of 75.5% achieved within 287 days.

Justin Kim’s has documented 110 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 06-Nov-2024.

Wall Street Analyst Justin Kim

Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for AUPH (AURINIA PHARMACEUTICALS) at 10/28/2021. The price target of $32 was fulfilled within 1 day with a profit of $2.04 (6.81%) receiving and performance score of 68.09.

Average potential price target upside

of $20.85 (65.25%) on ANGN (ANGION BIOMEDICA CORP).
of $19.24 (50.38%) on APLS (APELLIS PHARMACEUTICALS).
of $17.09 (35.38%) on CYTK (CYTOKINETICS).

ANGN Angion Biomedica Corp APLS Apellis Pharmaceuticals AUPH Aurinia Pharmaceuticals BCRX BioCryst Pharmaceuticals CYTK Cytokinetics PRVB Provention Bio PHVS Pharvaris BV ALDX Aldeyra The IMCR Immunocore Holdings Ltd KDNY Chinook Therapeutics IONS Ionis Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Raghuram Selvaraju (HC WAINWRIGHT)